Metizoline

Metizoline
Clinical data
Trade names	Ellsyl
Routes of; administration	Nasal
ATC code	R01AA10 (WHO) ;
Identifiers
	IUPAC name 2-[(2-methyl-1-benzothien-3-yl)methyl]-4,5-dihydro-1H-imidazole;
CAS Number	17692-22-7 ;
PubChem CID	28688;
ChemSpider	26683 ;
UNII	Z27L8N105U;
KEGG	D05006 ;
CompTox Dashboard (EPA)	DTXSID9074983 ;
Chemical and physical data
Formula	C13H14N2S
Molar mass	230.33 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC1=C(C2=CC=CC=C2S1)CC3=NCCN3;
	InChI InChI=1S/C13H14N2S/c1-9-11(8-13-14-6-7-15-13)10-4-2-3-5-12(10)16-9/h2-5H,6-8H2,1H3,(H,14,15) ; Key:NDNKHWUXXOFHTD-UHFFFAOYSA-N ;
	(what is this?) (verify)

Metizoline (trade name Ellsyl) is a nasal decongestant against allergic and vasomotor rhinitis.^[1]

References[edit]

^ Zumpft CW (January 1975). "Double-blind comparison of metizoline hydrochloride (Ellsyl) and phenylephrine in allergic and vasomotor rhinitis". Current Therapeutic Research, Clinical and Experimental. 17 (1): 40–6. PMID 49255.

This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it.